Preview Mode Links will not work in preview mode

Mar 12, 2020

A presentation on breast cancer featuring perspectives from Dr Sara Hurvitz.

  • Introduction (00:00)
  • Chemotherapy with Immunotherapy as First-Line Treatment for Metastatic Triple-Negative Breast Cancer (00:53)
  • T-DM1 for Residual HER2-Positive Disease After Neoadjuvant Therapy (12:17)
  • PARP Inhibitors in Metastatic Breast Cancer (19:37)
  • PI3 Kinase Inhibitors in Hormone Receptor-Positive Metastatic Disease (26:47)
  • Novel HER2-Directed Investigational Approaches (34:15)

CME information and select publications